EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

5 FDF Dossiers, 5 Europe

5 FDF Dossiers
5 Europe

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 36 NEWS #PharmaBuzz

media
2 DATA COMPILATION #PharmaFlow
36 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

5 Finished Drug Prices, 3 Annual Reports

globalSalesInformation
5 Finished Drug Prices
3 Annual Reports

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

906

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Umeclidinium/vilanterol, Vilanterol / umeclidinium, Umeclidinium and vilanterol, Umeclidinium bromide / vilanterol, Umeclidinium bromide and vilanterol, Gsk 573719

Molecular Formula

C₅₃H₆₇BrCl₂N₂O₇

Molecular Weight

994.9 g/mol

InChI Key

MDHKCIIEVIPVLU-JERHFGHZSA-M

1 2D Structure

Ellipta

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

4-[(1R)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide

2.1.2 InChI

InChI=1S/C29H34NO2.C24H33Cl2NO5.BrH/c31-29(26-12-6-2-7-13-26,27-14-8-3-9-15-27)28-16-19-30(20-17-28,21-18-28)22-23-32-24-25-10-4-1-5-11-25;25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28;/h1-15,31H,16-24H2;5-9,14,24,27-30H,1-4,10-13,15-17H2;1H/q+1;;/p-1/t;24-;/m.0./s1

2.1.3 InChI Key

MDHKCIIEVIPVLU-JERHFGHZSA-M

2.1.4 Canonical SMILES

C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl.[Br-]

2.1.5 Isomeric SMILES

C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl.[Br-]

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Umeclidinium/vilanterol

2. Vilanterol / Umeclidinium

3. Umeclidinium And Vilanterol

4. Umeclidinium Bromide / Vilanterol

5. Umeclidinium Bromide And Vilanterol

6. Gsk 573719

7. Umeclidinium Bromide Mixture With Vilanterol

8. S900006130

2.3 Create Date

2013-04-19

3 Chemical and Physical Properties

Molecular Formula	C₅₃H₆₇BrCl₂N₂O₇
Molecular Weight	994.9 g/mol
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	24
Exact Mass	992.35087 g/mol
Monoisotopic Mass	992.35087 g/mol
Topological Polar Surface Area	121 Å²
Heavy Atom Count	65
Formal Charge	0
Complexity	1010
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	3

4 Drug and Medication Information

4.1 Drug Information

1 of 2
Drug Name	Anoro ellipta
PubMed Health	Umeclidinium/Vilanterol (By breathing)
Drug Classes	Mucolytic, Respiratory Agent
Active Ingredient	vilanterol trifenatate; Umeclidinium bromide
Dosage Form	Powder
Route	Inhalation
Strength	eq 0.025mg base/inh; eq 0.0625mg base/inh
Market Status	Prescription
Company	Glaxosmithkline

2 of 2
Drug Name	Anoro ellipta
PubMed Health	Umeclidinium/Vilanterol (By breathing)
Drug Classes	Mucolytic, Respiratory Agent
Active Ingredient	vilanterol trifenatate; Umeclidinium bromide
Dosage Form	Powder
Route	Inhalation
Strength	eq 0.025mg base/inh; eq 0.0625mg base/inh
Market Status	Prescription
Company	Glaxosmithkline